Rapport du Groupe de travail sur les indicateurs d’évaluation : Lignes directrices pour la surveillance de la performance des programmes de dépistage du cancer du sein - Deuxième édition

Références

1. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA 1995;273:149-54.
2. The Workshop Group. Reducing deaths from breast cancer in Canada. Can Med Assoc J 1989;141;199-201.
3. Gaudette LA, Altmayer CA, Nobrega KMP, Lee J. Tendances relatives à l’utilisation de la mammographie, 1981 à 1994. Rapports sur la santé 1996;8(3).
4. Horne T, Groupe de travail sur les indicateurs d’évaluation. Proposed indicators for performance and quality of breast screening programs in Canada. Ottawa: Santé Canada, avril 2000.
5. Santé Canada. Rapport du Groupe de travail sur les indicateurs d’évaluation : lignes directrices pour la surveillance de la performance des programmes de dépistage du cancer du sein. Ottawa : Ministre de Travaux publics et Services gouvernementaux Canada, 2002.
6. Santé Canada. Programmes organisés de dépistage du cancer du sein au Canada en 2001 et 2002. Ottawa : Ministre de Travaux publics et Services gouvernementaux Canada, 2005
7. Europe Against Cancer. European guidelines for quality assurance in mammographic screening. Luxembourg: Office des publications officielles des Communautés européennes, janvier 2001.
8. Consolidated Guidance on Standards for the NHS Breast Screening Programme. Avril 2005 Sheffield, England: NHSBSP publication.
9. National Quality Management Committee of BreastScreen Australia. Draft National Accreditation Standards: BreastScreen Australia Quality Improvements Program. Juin 2001.
10. Wilson JMG, Jungner G. Principes et pratique du dépistage des maladies. Genève: Organisation mondiale de la santé, 1968.
11. Day NE, Williams DRR, Khaw KT. Breast cancer screening programs: the development of a monitoring and evaluation system. Br J Cancer 1989;59:954-58.
12. Tabar l, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, et al. Efficacy of breast cancer screening by age: new results from the Swedish two-county trial. Cancer 1995;75:2507-17.
13. Nyström L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Ryden S et al. Breast cancer screening with mammography: overview of the Swedish randomized trials. Lancet 1993;341:973-8.
14. Duffy SW, Hill C, Estève J. Quantitative methods for the evaluation of cancer screening. London: Arnold, 2001.
15. Société canadienne du cancer/Institut national du cancer du Canada: Statistiques canadiennes sur le cancer 2005, Toronto, Canada, 2005.
16. Evans AJ, Pinder SE, Ellis IO, Wilson ARM. Screen detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease? J Med Screen 2001;8:149-51.
17. Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: 1. The palpable breast lump: information and recommendations to assist decision-making when a breast lump is detected. Can Med Assoc J 1998;158(suppl):3S-8S.
18. Olivotto IA, Bancej C, Goel V, Snider J, McAuley RG, Irvine B, Kan L, Mirsky D, Sabine MJ, McGilly R, Caines JS. Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces. Can Med Assoc J. 2001;165(3):303-4.
19. Blanks RG, Moss SM, Wallis MG, Monitoring and evaluating the UK National Health Service Breast Screening Programme: evaluating the variation in radiological performance between individual programmes using PPV-referral diagrams. J Med Screen 2001;8:24-8.
20. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 1992;30:187-209.
21. Caines JS, Schaller GH, Iles SE, Woods ER, Barnes PJ, Johnson AJ, Jones GR, Borgaonkar JN, Rowe JA, Topp TJ, Porter GA. Ten years of breast screening in the Nova Scotia Breast Screening Program, 1991-2001. experience: use of an adaptable stereotactic device in the diagnosis of screening-detected abnormalities. Can Assoc Radiol J 2005:56(2):82-93.
22. Europe Against Cancer. European guidelines for quality assurance in mammographic screening. Luxembourg: Office des publications officielles des Communautés européennes, juin 1996.
23. Commonwealth Department of Human Services and Health. National program for the early detection of breast cancer: national accreditation requirements. Canberra, Australia: Commonwealth Department of Human Services and Health, mars 1994.
24. Moss SM, Blanks RG. Calculating appropriate target cancer detection rates and expected interval cancer rates for the UK NHS Breast Screening Programme. J Epidemiol Community Health 1998;52:111-15.
25. Rickard MT, Taylor RJ, Fazli MA, El Hassan N. Interval breast cancers in an Australian mammographic screening program. Med J Aust 1998;169:184-87.
26. Cahier de santé publique no 34, Organisation mondiale de la santé, 1968.